Article
Establishment of a novel human cell line retaining the characteristics of the original pancreatic adenocarcinoma, and evaluation of MEK as a therapeutic target.
International journal of oncology - 1 Mar 2020
Du Xiaoxiao, He Kuifeng, Huang Yingying, Xu Zhenzhen, Kong Mei, Zhang Jing, Cao Jiang, Teng Lisong
Abstract excerpt
Pancreatic cancer is a lethal solid malignancy with limited therapeutic options. The development of novel therapeutic drugs requires adequate new cell line models. A new pancreatic cancer cell line, designated PDXPC1, was established from one pancreatic ductal adenocarcinoma (PDAC) patient‑derived xenograft. The PDXPC1 cells were stably cultured for >2 years and had a stable short tandem repeat profile. The...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
